I am an independent pharmaceutical development professional offering advisory and consultative support focused in the areas of 1) sourcing analysis and implementation; 2) CDMO business development; 3) clinical development through commercialization approaches; and 4) environmental sustainability. I am a current Advisory Board member at two Southern CA based companies (1) Karmanterra, focusing on innovative climate solutions and (2) AEQUOR, Inc., aiming to solve microbial contamination issues with earth friendly approaches. I retired from Pfizer in 2023 following a wide-ranging 31-year career journey in the Pharmaceutical Sciences organization. My last Pfizer position was Senior Director, Drug Product Supply Strategy, where I had the opportunity to influence many supplier relationships across the development through commercial launch space. My roles have included leadership of global teams and initiatives, accountability for sourcing and manufacturing oversight of products for clinical trial use, direct facility support for clinical scale sterile manufacturing, drug delivery technology evaluation and development, as well as formulation development and analytical characterization responsibilities. Prior to joining Pfizer, I held environmental science positions that included laboratory and on-site characterization and remediation at a multitude of locations across the US. I have been based in Southern CA since 2017 after having spent most of my life on the East Coast, including 25 years at Pfizer's Groton CT site. In addition to my decades of industrial experience, I have a BS degree in Chemistry from Central Connecticut State University. I am looking forward to helping emerging companies and their products reach their full potential through innovative collaborations and approaches.